These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2544288)

  • 1. Initial clinical experience with the use of subcutaneous GR43175 in treating acute migraine.
    Brion N; Bons J; Plas J; Bayliss EM; Advenier C
    Cephalalgia; 1989; 9 Suppl 9():79-82. PubMed ID: 2544288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acute migraine with subcutaneous GR43175 in West Germany.
    Baar HA; Brand J; Doenicke A; Melchart D; Lüben V; Tryba M; Sahlender HM
    Cephalalgia; 1989; 9 Suppl 9():83-7. PubMed ID: 2544289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective improvement of symptoms in patients with acute migraine by GR43175 administered in dispersible tablets.
    Doenicke A; Melchart D; Bayliss EM
    Cephalalgia; 1989; 9 Suppl 9():89-92. PubMed ID: 2544290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of initial clinical studies with intravenous and oral GR43175 in acute migraine.
    Perrin VL; Färkkilä M; Goasguen J; Doenicke A; Brand J; Tfelt-Hansen P
    Cephalalgia; 1989; 9 Suppl 9():63-72. PubMed ID: 2544286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early clinical experience with subcutaneous GR43175 in acute migraine: an overview.
    Tfelt-Hansen P; Brand J; Dano P; Doenicke A; Findley LJ; Iversen HK; Melchart D; Sahlender HM
    Cephalalgia; 1989; 9 Suppl 9():73-7. PubMed ID: 2544287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine.
    Doenicke A; Brand J; Perrin VL
    Lancet; 1988 Jun; 1(8598):1309-11. PubMed ID: 2897560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sumatriptan injection is superior to placebo in the acute treatment of migraine--with regard to both efficacy and general well-being.
    Dahlöf C; Edwards C; Toth A
    Cephalalgia; 1992 Aug; 12(4):214-20. PubMed ID: 1326404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of subcutaneous sumatriptan in the acute treatment of early-morning migraine: a placebo-controlled trial. Early-Morning Migraine Sumatriptan Study Group.
    Bousser MG; D'Allens H; Richard A
    J Intern Med; 1993 Aug; 234(2):211-6. PubMed ID: 8393474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache.
    Dechant KL; Clissold SP
    Drugs; 1992 May; 43(5):776-98. PubMed ID: 1379152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous sumatriptan in acute treatment of migraine: a multicentre New Zealand trial.
    Thomson AN; Arthur GP; Bergin PS; Pollock M; Parkin PJ; Flanagan M; Samson SA
    N Z Med J; 1993 May; 106(955):171-3. PubMed ID: 8389026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group.
    Visser WH; Ferrari MD; Bayliss EM; Ludlow S; Pilgrim AJ
    Cephalalgia; 1992 Oct; 12(5):308-13. PubMed ID: 1330318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute migraine with subcutaneous sumatriptan.
    Cady RK; Wendt JK; Kirchner JR; Sargent JD; Rothrock JF; Skaggs H
    JAMA; 1991 Jun; 265(21):2831-5. PubMed ID: 1851894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of subcutaneous sumatriptan in repeated episodes of migraine.
    Cady RK; Dexter J; Sargent JD; Markley H; Osterhaus JT; Webster CJ
    Neurology; 1993 Jul; 43(7):1363-8. PubMed ID: 8392150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group.
    Eur Neurol; 1991; 31(5):323-31. PubMed ID: 1653140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early studies with the novel 5-HT 1-like agonist GR43175 in healthy volunteers.
    Fowler PA; Thomas M; Lacey LF; Andrew P; Dallas FA
    Cephalalgia; 1989; 9 Suppl 9():57-62. PubMed ID: 2544285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sumatriptan: a selective 5-hydroxytryptamine receptor agonist for the acute treatment of migraine.
    Fullerton T; Gengo FM
    Ann Pharmacother; 1992 Jun; 26(6):800-8. PubMed ID: 1319244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous sumatriptan in the acute treatment of migraine. Sumatriptan International Study Group.
    Ensink FB
    J Neurol; 1991; 238 Suppl 1():S66-9. PubMed ID: 1646291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of migraine attacks with sumatriptan.
    Subcutaneous Sumatriptan International Study Group
    N Engl J Med; 1991 Aug; 325(5):316-21. PubMed ID: 1647495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sumatriptan in the acute treatment of migraine.
    Tansey MJ; Pilgrim AJ; Lloyd K
    J Neurol Sci; 1993 Jan; 114(1):109-16. PubMed ID: 8381852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sumatriptan for the treatment of migraine attacks--a review of controlled clinical trials.
    Tfelt-Hansen P
    Cephalalgia; 1993 Aug; 13(4):238-44. PubMed ID: 8397070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.